Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.

Digestive diseases (Basel, Switzerland) - 1 Jan 2015

Traussnigg Stefan, Kienbacher Christian, Halilbasic Emina, Rechling Christian, Kazemi-Shirazi Lili, Hofer Harald, Munda Petra, Trauner Michael

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and comprises a liver disease spectrum ranging from steatosis to nonalcoholic steatohepatitis (NASH) with risk of progression to liver cirrhosis and hepatocellular carcinoma (HCC). Associated metabolic conditions and comorbidities such as obesity, diabetes and cardiovascular diseases are common and require concerted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Bariatric Surgery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Lipase

Share to Metformin

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity, Morbid

Share to Vitamin E

Source

Identifiers

PMID: 26159280
DOI: 10.1159/000375353

Genes

PNPLA3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.PMID 26159280Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

Present and future therapeutic strategies in non-alcoholic fatty liver disease.Semantic proximity Read ↗

Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging TherapiesSemantic proximity Read ↗

Obesity and the liver: nonalcoholic fatty liver disease.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Non-alcoholic Fatty Liver Disease (NAFLD) Management in the CommunitySemantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.Semantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.